Targeted radiation therapy (TRT) is undergoing another renaissance attributable to US Food
and Drug Administration approvals of 223RaCl2 (Xofigo; Bayer) and 177Lu-DOTATATE …

We read with interest the letter by Giammarile et al.[1] addressing our editorial in which we
proposed that the European Medicines Agency should allow the option of a dosimetrybased …

In 2013, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the National
Cancer Institute (NCI) partnered for the first time to host a joint workshop on targeted …

This supplement to The Journal of Nuclear Medicine includes 7 articles that address several
of the critical facets of the current state of radiation dosimetry in radiopharmaceutical …

(Optimisation) states: BFor all medical exposure of patients for radiotherapeutic purposes,
exposures of target volumes shall be individually planned and their delivery appropriately …

This article deals primarily with the selection criteria, production, and the nuclear, physical,
and chemical properties of certain dual-purpose radionuclides, including those that are …

Radiopharmaceuticals play a key role in medicine. In addition to being a diagnostic tool,
they are also used therapeutically in the treatment of cancer; radioactive iodine-131 has …

This chapter will focus primarily on the selection criteria, production, and the nuclear,
physical, and chemical properties of therapeutic radionuclides, including those that are …

A search in PubMed revealed that 72 radionuclides have been considered for molecular or
functional targeted radionuclide therapy. As radionuclide therapies increase in number and …

Radiopharmaceutical therapy (RPT) involves the use of radionuclides that are either
conjugated to tumor-targeting agents (eg, nanoscale constructs, antibodies, peptides, and …